No Data
No Data
MediPharm Labs Q1 Gross Profit, Rise
MediPharm Labs (LABS.TO) reported Wednesday higher gross profit and revenue in the first quarter compared to the same period a year ago. The cannabinoids-focused pharmaceutical company booked a gross
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results for the first quarter ended March 31, 2024. The pharmaceutical company specializing in precision-based cannabin
MediPharm Labs Corp. Brief: Anticipates Further Improvement on Profitability in 2024 With Plans Being Implemented to Improve Adjusted EBITDA by a Further $1-$2 Million
06:25 AM EDT, 05/15/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Anticipates further improvement on profitability in 2024 with plans being implemented to improve Adjusted EBITDA by a further $1-
MediPharm Labs Corp. Brief: Revenue Increased 67% to $9.8 Million During the Three Months Ended March 31, 2024, Versus Revenue for the Same Quarter in 2023 of $5.8 Million
06:19 AM EDT, 05/15/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Revenue increased 67% to $9.8 Million during the three months ended March 31, 2024, versus revenue for the same quarter in 2023 o
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the full year and three months ended Dec. 31, 2023.Net revenue grew to CA$33 million ($24.3 mi
Earnings Call Summary | MEDIPHARM LABS CORP(MEDIF.US) Q4 2023 Earnings Conference
The following is a summary of the MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript:Financial Performance:MediPharm reported Q4 2023 revenue of $9.1 million, a 63% increase compared to the